Access full year 2011 revenues increase 284 percent ACCESS PHARMACEUTICALS.

, a biopharmaceutical firm leveraging its proprietary drug-delivery platforms to develop treatments in areas of cancer and oncology supportive care,announced preliminary revenue results for fourth quarter 2011 and full year 2011. Morning Wednesday, the Company will show at the Cowen and Organization 32nd Annual HEALTHCARE Conference, at The Boston Marriott Copley Place in Boston, MA. Jeffrey Davis, CEO of Access Pharmaceuticals, will give a presentation updating traders on recent commercial advancements within its lead program for oral mucositis, MuGard, and other product applications. This pain reliever most people know as Tylenol might help a headache, ease chronic joint or body pain, and reduce a fever. Continue reading